Varenicline improves motor and cognitive symptoms in early Huntington’s disease
Ailsa L McGregor,1,2 Jo Dysart,3 Malcolm D Tingle,4 Bruce R Russell,1,2 Rob R Kydd,5 Gregory Finucane2 1New Zealand’s National School of Pharmacy, Division of Health Sciences, University of Otago, Dunedin, New Zealand; 2Centre for Brain Research, University of Auckland, 3Liaison Psychiatr...
Guardado en:
Autores principales: | McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d434258d59e242baa2cc61b808c0df70 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Journal of Huntington's disease
-
The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease
por: Klaudia Plinta, et al.
Publicado: (2021) -
Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway
por: Joshua Barry, et al.
Publicado: (2022) -
Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: Huajing You, et al.
Publicado: (2021) -
Oral treatment with herbal formula B307 alleviates cardiac failure in aging R6/2 mice with Huntington’s disease via suppressing oxidative stress, inflammation, and apoptosis
por: Lin CL, et al.
Publicado: (2015)